
Revolution in Medicine: BioNTech, mRNA and the Covid-19 Vaccine
Scientists Uğur Şahin and Özlem Türeci spent two decades chasing personalized cancer treatments before a January 2020 news item about a virus in Wuhan sent their company, BioNTech, racing toward a vaccine within hours. Filmmaker Michael Schindhelm gets access inside the Mainz, Germany startup to trace how mRNA technology, which delivers instructions for antigen production directly into cells, moved from cancer research into a global immunization campaign. The film covers the scramble for funding, including early backing from Hexal founders Andreas and Thomas Strünmann, the partnership with Pfizer that accelerated testing, and the approval of the Comirnaty vaccine. Interviews with researchers and footage inside BioNTech's labs lay out the science in plain terms, while the film also looks ahead to whether the same mRNA platform could work against cancer and malaria. It is a company profile as much as a science explainer, built around the two scientists whose two-decade side project became one of the fastest vaccine developments in history.